S.Korea's COVID-19 test kit makers, vaccine makers fall after Pfizer vaccine report
** Shares of South Korean Covid-19 test kit makers and
vaccine makers lose ground
** Pfizer Inc's PFE.N experimental COVID-19 vaccine is
more than 90% effective based on initial trial results, the
drugmaker said on Monday urn:newsml:reuters.com:*:nL1N2HV0TR
** Shares of Seegene 096530.KQ , South Korea's top listed
COVID-19 test kit maker, falls 7.3%, its peer SugenTech
253840.KQ slumps 7.5%
** Celltrion Inc 068270.KS , which is developing a COVID-19
treatment, falls 2.6%, Genexine 095700.KQ , also developing a
COVID-19 vaccine, slumps 7.5%
** The broader KOSPI market .KS11 was trading down 0.2%
((hyunjoo.jin@thomsonreuters.com; 82-2-3704-5685))
Recent news on Celltrion Healthcare Co
See all newsBrief: Celltrion USA says Ventegra Will Place FDA-Approved Biosimilar To Avastin , Vegzelma On Its Commercial Formulary As A Preferred Brand
Brief: Celltrion Healthcare To Acquire 92.7 Billion Won Worth Of Own Shares
Brief: Celltrion Healthcare Q3 Operating Profit 50.5 Billion Won, Down 30.4% From Year Earlier
Brief: Celltrion Usa- Announces Distribution And Incorporation Of Yuflyma (Adalimumab-Aaty) To Carepartners Specialty Pharmacy Cost Savings Programs
Brief: Celltrion Healthcare's Merger With Celltrion Approved In Shareholder Meeting -Yonhap